![]() Current News
September 05, 2014
Directors Nominated By Dissident Shareholder Elected At Annual General Meeting
September 04, 2014
Med BioGene Announces Receipt of Proxies for Upcoming Annual and Special Meeting
August 06, 2014
Med BioGene Announces Director Nominations and Postponement of Annual and Special Meeting
March 07, 2014
Med BioGene Announces Publication of Data Demonstrating Independent Validation of GeneFx® Lung
January 09, 2014
Med BioGene Announces Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC
| Neil Campbell, the CEO of Helomics®, Message on Cancer Video
Neil Campbell, the CEO of Helomics® Corporation, the licensee responsible of the commercialization of GeneFx Lung®, Med BioGene's proprietary prognostic genomic based test procedure for early stage non-small cell lung cancers, NSCLC, talks about Helomics® approach to personalized medicine. The video was produced in the Helomics® CLIA approved laboratory at their headquarters in Pittsburgh. |
|
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer